# Oxular: Biotechnology, Oxford, United Kingdom

> Oxular: Oxular Limited, based in Oxford, United Kingdom, is a clinical-stage biotechnology company focused on developing innovative drug-device combination...

Source: https://millionrounds.com/startup/oxular (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# Oxular

Oxular Limited, based in Oxford, United Kingdom, is a clinical-stage biotechnology company focused on developing innovative drug-device combination treatments for retinal diseases.

Funding reported Last round: Series B

Biotechnology Oxford, United Kingdom

Company summary

- **Founded:** 2014 12 years old
- **Team:** 4 1 to 10 people
- **Funding reported:** 76.7M as listed, currency not stated
- **Last round:** Series B Mar 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Oxular has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Oxular

Oxular Limited, based in Oxford, United Kingdom, is a clinical-stage biotechnology company focused on developing innovative drug-device combination treatments for retinal diseases.

Founded in 2014 by Tom Cavanagh and Ronald K. Yamamoto, Oxular aims to improve the treatment of sight-threatening conditions by providing safe and effective therapeutics that require less frequent dosing. The company specializes in a proprietary drug delivery technology that utilizes a minimally invasive suprachoroidal microcatheter device, known as Oxulumis. This device allows for precise drug administration to the posterior eye, enhancing therapeutic effectiveness while minimizing side effects. Oxular's lead candidate, OXU-001, is designed for the treatment of Diabetic Macular Edema and has received Investigational New Drug clearance from the FDA. The company is also advancing clinical trials for various retinal diseases, including Diabetic Retinopathy and Age-Related Macular Degeneration. In January 2025, Oxular was acquired by Regeneron Pharmaceuticals, expanding its capabilities in the retinal therapeutics market.

## What company datasets say Oxular raised

Funding, as reported

Reported in all **76.7M** in the source's currency

Rounds **3**

Last round **Series B**

Last round size **37M**

Last round date **Mar 2021**

Investors listed **6**

## Funding filed with regulators

Oxular filed 2 raises, $21M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Dec 2024 **$11M** UK share allotment
- Nov 2022 **$10M** UK share allotment

## The company, in detail

What they build

Known for

health care large-scale data analysis monoclonal antibodies distribution biologics development manufacturing cell therapy genetic association studies medical research oxulumis oxuflo education information technology & services bispecific antibodies logistics & supply chain ocular

Built with from their website

Adobe Wistia Google Tag Manager Salesforce Service Cloud HREF Lang Atlassian LiveRamp Linkedin Insight Tag DataTables Salesforce Live Agent

+8 more

Salesforce Lightning Web Components Dv360 CloudFlare Viewport Meta Atlassian Cloud Element UI DemandBase WP Engine

- **Sector:** Biotechnology
- **Industry code:** NAICS 32541, SIC 2834
- **Region:** England
- **Part of:** Regeneron
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/oxular)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)
- [**PhoreMost Ltd** Cambridge · founded 2014](https://millionrounds.com/startup/phoremost-ltd)

## Is this your company?

Add your raise, your deck and your story, and put Oxular in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)